nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—stomach cancer	0.165	1	CbGaD
Tacrolimus—ABCB1—Mitomycin—stomach cancer	0.0646	0.173	CbGbCtD
Tacrolimus—CYP3A7—Irinotecan—stomach cancer	0.034	0.0907	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.034	0.0907	CbGbCtD
Tacrolimus—ALB—Irinotecan—stomach cancer	0.0317	0.0846	CbGbCtD
Tacrolimus—ALB—Fluorouracil—stomach cancer	0.0304	0.0812	CbGbCtD
Tacrolimus—CYP3A5—Irinotecan—stomach cancer	0.0255	0.068	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0249	0.0664	CbGbCtD
Tacrolimus—CYP3A7—Docetaxel—stomach cancer	0.0249	0.0664	CbGbCtD
Tacrolimus—CYP3A5—Docetaxel—stomach cancer	0.0187	0.0498	CbGbCtD
Tacrolimus—ALB—Methotrexate—stomach cancer	0.0168	0.0448	CbGbCtD
Tacrolimus—ABCB1—Irinotecan—stomach cancer	0.0166	0.0443	CbGbCtD
Tacrolimus—ABCB1—Docetaxel—stomach cancer	0.0121	0.0324	CbGbCtD
Tacrolimus—CYP3A4—Irinotecan—stomach cancer	0.00993	0.0265	CbGbCtD
Tacrolimus—ABCB1—Doxorubicin—stomach cancer	0.00906	0.0242	CbGbCtD
Tacrolimus—ABCB1—Methotrexate—stomach cancer	0.00877	0.0234	CbGbCtD
Tacrolimus—ORM1—bile—stomach cancer	0.008	0.0996	CbGeAlD
Tacrolimus—CYP3A4—Docetaxel—stomach cancer	0.00728	0.0194	CbGbCtD
Tacrolimus—CYP3A4—Doxorubicin—stomach cancer	0.00543	0.0145	CbGbCtD
Tacrolimus—MTOR—blood vessel—stomach cancer	0.00335	0.0417	CbGeAlD
Tacrolimus—ABCA5—pancreas—stomach cancer	0.00291	0.0363	CbGeAlD
Tacrolimus—PPP3CA—hematopoietic system—stomach cancer	0.00242	0.0301	CbGeAlD
Tacrolimus—ABCA5—bone marrow—stomach cancer	0.00229	0.0286	CbGeAlD
Tacrolimus—ORM1—gall bladder—stomach cancer	0.00222	0.0277	CbGeAlD
Tacrolimus—PPP3CA—smooth muscle tissue—stomach cancer	0.00213	0.0265	CbGeAlD
Tacrolimus—ABCA5—endocrine gland—stomach cancer	0.00206	0.0256	CbGeAlD
Tacrolimus—PPP3CA—pancreas—stomach cancer	0.00197	0.0245	CbGeAlD
Tacrolimus—ALB—gall bladder—stomach cancer	0.00195	0.0243	CbGeAlD
Tacrolimus—ABCA5—liver—stomach cancer	0.00185	0.0231	CbGeAlD
Tacrolimus—MTOR—hematopoietic system—stomach cancer	0.00179	0.0222	CbGeAlD
Tacrolimus—PPP3CA—lymphoid tissue—stomach cancer	0.0017	0.0212	CbGeAlD
Tacrolimus—PPP3CA—digestive system—stomach cancer	0.00168	0.0209	CbGeAlD
Tacrolimus—MTOR—epithelium—stomach cancer	0.00163	0.0203	CbGeAlD
Tacrolimus—FKBP1A—hematopoietic system—stomach cancer	0.00161	0.02	CbGeAlD
Tacrolimus—MTOR—smooth muscle tissue—stomach cancer	0.00157	0.0196	CbGeAlD
Tacrolimus—PPP3CA—bone marrow—stomach cancer	0.00155	0.0193	CbGeAlD
Tacrolimus—FKBP1A—epithelium—stomach cancer	0.00147	0.0183	CbGeAlD
Tacrolimus—MTOR—pancreas—stomach cancer	0.00145	0.0181	CbGeAlD
Tacrolimus—ABCA5—lymph node—stomach cancer	0.00142	0.0177	CbGeAlD
Tacrolimus—FKBP1A—smooth muscle tissue—stomach cancer	0.00141	0.0176	CbGeAlD
Tacrolimus—PPP3CA—endocrine gland—stomach cancer	0.00139	0.0173	CbGeAlD
Tacrolimus—FKBP1A—pancreas—stomach cancer	0.00131	0.0163	CbGeAlD
Tacrolimus—ORM1—hematopoietic system—stomach cancer	0.00126	0.0157	CbGeAlD
Tacrolimus—MTOR—lymphoid tissue—stomach cancer	0.00126	0.0156	CbGeAlD
Tacrolimus—PPP3CA—liver—stomach cancer	0.00125	0.0156	CbGeAlD
Tacrolimus—MTOR—digestive system—stomach cancer	0.00124	0.0155	CbGeAlD
Tacrolimus—MTOR—bone marrow—stomach cancer	0.00114	0.0142	CbGeAlD
Tacrolimus—CYP3A7—endocrine gland—stomach cancer	0.00114	0.0142	CbGeAlD
Tacrolimus—FKBP1A—lymphoid tissue—stomach cancer	0.00113	0.0141	CbGeAlD
Tacrolimus—FKBP1A—digestive system—stomach cancer	0.00112	0.0139	CbGeAlD
Tacrolimus—FKBP1A—bone marrow—stomach cancer	0.00103	0.0128	CbGeAlD
Tacrolimus—CYP3A7—liver—stomach cancer	0.00103	0.0128	CbGeAlD
Tacrolimus—MTOR—endocrine gland—stomach cancer	0.00103	0.0128	CbGeAlD
Tacrolimus—PPP3CA—lymph node—stomach cancer	0.00096	0.012	CbGeAlD
Tacrolimus—MTOR—liver—stomach cancer	0.000925	0.0115	CbGeAlD
Tacrolimus—FKBP1A—endocrine gland—stomach cancer	0.000923	0.0115	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—liver—stomach cancer	0.000875	0.0109	CbGeAlD
Tacrolimus—FKBP1A—liver—stomach cancer	0.000832	0.0104	CbGeAlD
Tacrolimus—ORM1—bone marrow—stomach cancer	0.000806	0.01	CbGeAlD
Tacrolimus—ORM1—endocrine gland—stomach cancer	0.000722	0.00899	CbGeAlD
Tacrolimus—MTOR—lymph node—stomach cancer	0.000709	0.00883	CbGeAlD
Tacrolimus—CYP3A5—hematopoietic system—stomach cancer	0.000699	0.00871	CbGeAlD
Tacrolimus—ABCB1—blood vessel—stomach cancer	0.000698	0.00868	CbGeAlD
Tacrolimus—ORM1—liver—stomach cancer	0.000651	0.00811	CbGeAlD
Tacrolimus—FKBP1A—lymph node—stomach cancer	0.000638	0.00794	CbGeAlD
Tacrolimus—ALB—liver—stomach cancer	0.000571	0.00711	CbGeAlD
Tacrolimus—CYP3A5—pancreas—stomach cancer	0.000569	0.00709	CbGeAlD
Tacrolimus—CYP3A4—hematopoietic system—stomach cancer	0.000525	0.00653	CbGeAlD
Tacrolimus—ORM1—lymph node—stomach cancer	0.000499	0.00622	CbGeAlD
Tacrolimus—CYP3A5—digestive system—stomach cancer	0.000486	0.00605	CbGeAlD
Tacrolimus—ALB—lymph node—stomach cancer	0.000438	0.00545	CbGeAlD
Tacrolimus—CYP3A5—endocrine gland—stomach cancer	0.000402	0.005	CbGeAlD
Tacrolimus—ABCB1—hematopoietic system—stomach cancer	0.000371	0.00462	CbGeAlD
Tacrolimus—CYP3A4—digestive system—stomach cancer	0.000365	0.00454	CbGeAlD
Tacrolimus—CYP3A5—liver—stomach cancer	0.000362	0.00451	CbGeAlD
Tacrolimus—ABCB1—epithelium—stomach cancer	0.00034	0.00423	CbGeAlD
Tacrolimus—ABCB1—pancreas—stomach cancer	0.000302	0.00377	CbGeAlD
Tacrolimus—CYP3A4—endocrine gland—stomach cancer	0.000302	0.00375	CbGeAlD
Tacrolimus—CYP3A4—liver—stomach cancer	0.000272	0.00338	CbGeAlD
Tacrolimus—ABCB1—lymphoid tissue—stomach cancer	0.000262	0.00326	CbGeAlD
Tacrolimus—ABCB1—digestive system—stomach cancer	0.000258	0.00322	CbGeAlD
Tacrolimus—ABCB1—bone marrow—stomach cancer	0.000238	0.00296	CbGeAlD
Tacrolimus—ABCB1—endocrine gland—stomach cancer	0.000213	0.00266	CbGeAlD
Tacrolimus—ABCB1—liver—stomach cancer	0.000192	0.0024	CbGeAlD
Tacrolimus—ABCB1—lymph node—stomach cancer	0.000148	0.00184	CbGeAlD
Tacrolimus—Paraesthesia—Capecitabine—stomach cancer	5.44e-05	0.000228	CcSEcCtD
Tacrolimus—Decreased appetite—Docetaxel—stomach cancer	5.44e-05	0.000228	CcSEcCtD
Tacrolimus—Headache—Fluorouracil—stomach cancer	5.43e-05	0.000228	CcSEcCtD
Tacrolimus—Urinary tract disorder—Doxorubicin—stomach cancer	5.43e-05	0.000228	CcSEcCtD
Tacrolimus—Oedema peripheral—Doxorubicin—stomach cancer	5.41e-05	0.000227	CcSEcCtD
Tacrolimus—Dysgeusia—Methotrexate—stomach cancer	5.41e-05	0.000227	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Docetaxel—stomach cancer	5.4e-05	0.000227	CcSEcCtD
Tacrolimus—Connective tissue disorder—Doxorubicin—stomach cancer	5.4e-05	0.000227	CcSEcCtD
Tacrolimus—Dyspnoea—Capecitabine—stomach cancer	5.4e-05	0.000227	CcSEcCtD
Tacrolimus—Fatigue—Docetaxel—stomach cancer	5.39e-05	0.000226	CcSEcCtD
Tacrolimus—Angiopathy—Epirubicin—stomach cancer	5.39e-05	0.000226	CcSEcCtD
Tacrolimus—Urethral disorder—Doxorubicin—stomach cancer	5.39e-05	0.000226	CcSEcCtD
Tacrolimus—Nausea—Irinotecan—stomach cancer	5.37e-05	0.000226	CcSEcCtD
Tacrolimus—Immune system disorder—Epirubicin—stomach cancer	5.36e-05	0.000225	CcSEcCtD
Tacrolimus—Mediastinal disorder—Epirubicin—stomach cancer	5.35e-05	0.000225	CcSEcCtD
Tacrolimus—Pain—Docetaxel—stomach cancer	5.35e-05	0.000224	CcSEcCtD
Tacrolimus—Constipation—Docetaxel—stomach cancer	5.35e-05	0.000224	CcSEcCtD
Tacrolimus—Back pain—Methotrexate—stomach cancer	5.34e-05	0.000224	CcSEcCtD
Tacrolimus—Dyspepsia—Capecitabine—stomach cancer	5.33e-05	0.000224	CcSEcCtD
Tacrolimus—Chills—Epirubicin—stomach cancer	5.33e-05	0.000224	CcSEcCtD
Tacrolimus—Arrhythmia—Epirubicin—stomach cancer	5.3e-05	0.000223	CcSEcCtD
Tacrolimus—Visual impairment—Doxorubicin—stomach cancer	5.29e-05	0.000222	CcSEcCtD
Tacrolimus—Decreased appetite—Capecitabine—stomach cancer	5.26e-05	0.000221	CcSEcCtD
Tacrolimus—Alopecia—Epirubicin—stomach cancer	5.25e-05	0.00022	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Capecitabine—stomach cancer	5.23e-05	0.000219	CcSEcCtD
Tacrolimus—Fatigue—Capecitabine—stomach cancer	5.22e-05	0.000219	CcSEcCtD
Tacrolimus—Vision blurred—Methotrexate—stomach cancer	5.2e-05	0.000218	CcSEcCtD
Tacrolimus—Mental disorder—Epirubicin—stomach cancer	5.2e-05	0.000218	CcSEcCtD
Tacrolimus—Erythema multiforme—Doxorubicin—stomach cancer	5.19e-05	0.000218	CcSEcCtD
Tacrolimus—Constipation—Capecitabine—stomach cancer	5.18e-05	0.000217	CcSEcCtD
Tacrolimus—Pain—Capecitabine—stomach cancer	5.18e-05	0.000217	CcSEcCtD
Tacrolimus—Erythema—Epirubicin—stomach cancer	5.17e-05	0.000217	CcSEcCtD
Tacrolimus—Malnutrition—Epirubicin—stomach cancer	5.17e-05	0.000217	CcSEcCtD
Tacrolimus—Feeling abnormal—Docetaxel—stomach cancer	5.15e-05	0.000216	CcSEcCtD
Tacrolimus—Nausea—Fluorouracil—stomach cancer	5.15e-05	0.000216	CcSEcCtD
Tacrolimus—Eye disorder—Doxorubicin—stomach cancer	5.13e-05	0.000215	CcSEcCtD
Tacrolimus—Ill-defined disorder—Methotrexate—stomach cancer	5.12e-05	0.000215	CcSEcCtD
Tacrolimus—Tinnitus—Doxorubicin—stomach cancer	5.12e-05	0.000215	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Docetaxel—stomach cancer	5.11e-05	0.000215	CcSEcCtD
Tacrolimus—Anaemia—Methotrexate—stomach cancer	5.1e-05	0.000214	CcSEcCtD
Tacrolimus—Cardiac disorder—Doxorubicin—stomach cancer	5.1e-05	0.000214	CcSEcCtD
Tacrolimus—Flushing—Doxorubicin—stomach cancer	5.1e-05	0.000214	CcSEcCtD
Tacrolimus—Flatulence—Epirubicin—stomach cancer	5.09e-05	0.000214	CcSEcCtD
Tacrolimus—Tension—Epirubicin—stomach cancer	5.07e-05	0.000213	CcSEcCtD
Tacrolimus—Dysgeusia—Epirubicin—stomach cancer	5.06e-05	0.000212	CcSEcCtD
Tacrolimus—Nervousness—Epirubicin—stomach cancer	5.02e-05	0.000211	CcSEcCtD
Tacrolimus—Back pain—Epirubicin—stomach cancer	5e-05	0.00021	CcSEcCtD
Tacrolimus—Feeling abnormal—Capecitabine—stomach cancer	4.99e-05	0.000209	CcSEcCtD
Tacrolimus—Angiopathy—Doxorubicin—stomach cancer	4.98e-05	0.000209	CcSEcCtD
Tacrolimus—Malaise—Methotrexate—stomach cancer	4.98e-05	0.000209	CcSEcCtD
Tacrolimus—Muscle spasms—Epirubicin—stomach cancer	4.97e-05	0.000209	CcSEcCtD
Tacrolimus—Immune system disorder—Doxorubicin—stomach cancer	4.96e-05	0.000208	CcSEcCtD
Tacrolimus—Vertigo—Methotrexate—stomach cancer	4.96e-05	0.000208	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Capecitabine—stomach cancer	4.95e-05	0.000208	CcSEcCtD
Tacrolimus—Mediastinal disorder—Doxorubicin—stomach cancer	4.95e-05	0.000208	CcSEcCtD
Tacrolimus—Abdominal pain—Docetaxel—stomach cancer	4.94e-05	0.000207	CcSEcCtD
Tacrolimus—Body temperature increased—Docetaxel—stomach cancer	4.94e-05	0.000207	CcSEcCtD
Tacrolimus—Leukopenia—Methotrexate—stomach cancer	4.94e-05	0.000207	CcSEcCtD
Tacrolimus—Chills—Doxorubicin—stomach cancer	4.93e-05	0.000207	CcSEcCtD
Tacrolimus—Arrhythmia—Doxorubicin—stomach cancer	4.91e-05	0.000206	CcSEcCtD
Tacrolimus—Vision blurred—Epirubicin—stomach cancer	4.87e-05	0.000204	CcSEcCtD
Tacrolimus—Alopecia—Doxorubicin—stomach cancer	4.85e-05	0.000204	CcSEcCtD
Tacrolimus—Cough—Methotrexate—stomach cancer	4.82e-05	0.000202	CcSEcCtD
Tacrolimus—Mental disorder—Doxorubicin—stomach cancer	4.81e-05	0.000202	CcSEcCtD
Tacrolimus—Urticaria—Capecitabine—stomach cancer	4.81e-05	0.000202	CcSEcCtD
Tacrolimus—Ill-defined disorder—Epirubicin—stomach cancer	4.8e-05	0.000201	CcSEcCtD
Tacrolimus—Abdominal pain—Capecitabine—stomach cancer	4.79e-05	0.000201	CcSEcCtD
Tacrolimus—Body temperature increased—Capecitabine—stomach cancer	4.79e-05	0.000201	CcSEcCtD
Tacrolimus—Convulsion—Methotrexate—stomach cancer	4.79e-05	0.000201	CcSEcCtD
Tacrolimus—Erythema—Doxorubicin—stomach cancer	4.78e-05	0.000201	CcSEcCtD
Tacrolimus—Malnutrition—Doxorubicin—stomach cancer	4.78e-05	0.000201	CcSEcCtD
Tacrolimus—Anaemia—Epirubicin—stomach cancer	4.78e-05	0.0002	CcSEcCtD
Tacrolimus—Agitation—Epirubicin—stomach cancer	4.75e-05	0.000199	CcSEcCtD
Tacrolimus—Flatulence—Doxorubicin—stomach cancer	4.71e-05	0.000198	CcSEcCtD
Tacrolimus—Chest pain—Methotrexate—stomach cancer	4.7e-05	0.000197	CcSEcCtD
Tacrolimus—Arthralgia—Methotrexate—stomach cancer	4.7e-05	0.000197	CcSEcCtD
Tacrolimus—Myalgia—Methotrexate—stomach cancer	4.7e-05	0.000197	CcSEcCtD
Tacrolimus—Tension—Doxorubicin—stomach cancer	4.69e-05	0.000197	CcSEcCtD
Tacrolimus—Dysgeusia—Doxorubicin—stomach cancer	4.68e-05	0.000197	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	4.67e-05	0.000196	CcSEcCtD
Tacrolimus—Malaise—Epirubicin—stomach cancer	4.66e-05	0.000196	CcSEcCtD
Tacrolimus—Discomfort—Methotrexate—stomach cancer	4.65e-05	0.000195	CcSEcCtD
Tacrolimus—Nervousness—Doxorubicin—stomach cancer	4.64e-05	0.000195	CcSEcCtD
Tacrolimus—Vertigo—Epirubicin—stomach cancer	4.64e-05	0.000195	CcSEcCtD
Tacrolimus—Syncope—Epirubicin—stomach cancer	4.63e-05	0.000195	CcSEcCtD
Tacrolimus—Leukopenia—Epirubicin—stomach cancer	4.63e-05	0.000194	CcSEcCtD
Tacrolimus—Back pain—Doxorubicin—stomach cancer	4.63e-05	0.000194	CcSEcCtD
Tacrolimus—Hypersensitivity—Docetaxel—stomach cancer	4.61e-05	0.000193	CcSEcCtD
Tacrolimus—Muscle spasms—Doxorubicin—stomach cancer	4.6e-05	0.000193	CcSEcCtD
Tacrolimus—Palpitations—Epirubicin—stomach cancer	4.57e-05	0.000192	CcSEcCtD
Tacrolimus—Confusional state—Methotrexate—stomach cancer	4.54e-05	0.000191	CcSEcCtD
Tacrolimus—Loss of consciousness—Epirubicin—stomach cancer	4.54e-05	0.000191	CcSEcCtD
Tacrolimus—Cough—Epirubicin—stomach cancer	4.51e-05	0.000189	CcSEcCtD
Tacrolimus—Anaphylactic shock—Methotrexate—stomach cancer	4.51e-05	0.000189	CcSEcCtD
Tacrolimus—Vision blurred—Doxorubicin—stomach cancer	4.51e-05	0.000189	CcSEcCtD
Tacrolimus—Asthenia—Docetaxel—stomach cancer	4.49e-05	0.000188	CcSEcCtD
Tacrolimus—Convulsion—Epirubicin—stomach cancer	4.48e-05	0.000188	CcSEcCtD
Tacrolimus—Infection—Methotrexate—stomach cancer	4.48e-05	0.000188	CcSEcCtD
Tacrolimus—Hypertension—Epirubicin—stomach cancer	4.46e-05	0.000187	CcSEcCtD
Tacrolimus—Hypersensitivity—Capecitabine—stomach cancer	4.46e-05	0.000187	CcSEcCtD
Tacrolimus—Ill-defined disorder—Doxorubicin—stomach cancer	4.44e-05	0.000186	CcSEcCtD
Tacrolimus—Pruritus—Docetaxel—stomach cancer	4.42e-05	0.000186	CcSEcCtD
Tacrolimus—Nervous system disorder—Methotrexate—stomach cancer	4.42e-05	0.000186	CcSEcCtD
Tacrolimus—Anaemia—Doxorubicin—stomach cancer	4.42e-05	0.000186	CcSEcCtD
Tacrolimus—Thrombocytopenia—Methotrexate—stomach cancer	4.41e-05	0.000185	CcSEcCtD
Tacrolimus—Arthralgia—Epirubicin—stomach cancer	4.4e-05	0.000185	CcSEcCtD
Tacrolimus—Chest pain—Epirubicin—stomach cancer	4.4e-05	0.000185	CcSEcCtD
Tacrolimus—Myalgia—Epirubicin—stomach cancer	4.4e-05	0.000185	CcSEcCtD
Tacrolimus—Agitation—Doxorubicin—stomach cancer	4.39e-05	0.000184	CcSEcCtD
Tacrolimus—Anxiety—Epirubicin—stomach cancer	4.38e-05	0.000184	CcSEcCtD
Tacrolimus—Skin disorder—Methotrexate—stomach cancer	4.38e-05	0.000184	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	4.37e-05	0.000183	CcSEcCtD
Tacrolimus—Hyperhidrosis—Methotrexate—stomach cancer	4.36e-05	0.000183	CcSEcCtD
Tacrolimus—Discomfort—Epirubicin—stomach cancer	4.35e-05	0.000182	CcSEcCtD
Tacrolimus—Asthenia—Capecitabine—stomach cancer	4.34e-05	0.000182	CcSEcCtD
Tacrolimus—Malaise—Doxorubicin—stomach cancer	4.31e-05	0.000181	CcSEcCtD
Tacrolimus—Dry mouth—Epirubicin—stomach cancer	4.3e-05	0.000181	CcSEcCtD
Tacrolimus—Vertigo—Doxorubicin—stomach cancer	4.3e-05	0.00018	CcSEcCtD
Tacrolimus—Anorexia—Methotrexate—stomach cancer	4.3e-05	0.00018	CcSEcCtD
Tacrolimus—Syncope—Doxorubicin—stomach cancer	4.29e-05	0.00018	CcSEcCtD
Tacrolimus—Pruritus—Capecitabine—stomach cancer	4.28e-05	0.00018	CcSEcCtD
Tacrolimus—Leukopenia—Doxorubicin—stomach cancer	4.28e-05	0.00018	CcSEcCtD
Tacrolimus—Diarrhoea—Docetaxel—stomach cancer	4.28e-05	0.00018	CcSEcCtD
Tacrolimus—Confusional state—Epirubicin—stomach cancer	4.25e-05	0.000179	CcSEcCtD
Tacrolimus—Palpitations—Doxorubicin—stomach cancer	4.23e-05	0.000177	CcSEcCtD
Tacrolimus—Anaphylactic shock—Epirubicin—stomach cancer	4.22e-05	0.000177	CcSEcCtD
Tacrolimus—Oedema—Epirubicin—stomach cancer	4.22e-05	0.000177	CcSEcCtD
Tacrolimus—Hypotension—Methotrexate—stomach cancer	4.21e-05	0.000177	CcSEcCtD
Tacrolimus—Loss of consciousness—Doxorubicin—stomach cancer	4.2e-05	0.000176	CcSEcCtD
Tacrolimus—Infection—Epirubicin—stomach cancer	4.19e-05	0.000176	CcSEcCtD
Tacrolimus—Cough—Doxorubicin—stomach cancer	4.17e-05	0.000175	CcSEcCtD
Tacrolimus—Shock—Epirubicin—stomach cancer	4.15e-05	0.000174	CcSEcCtD
Tacrolimus—Convulsion—Doxorubicin—stomach cancer	4.14e-05	0.000174	CcSEcCtD
Tacrolimus—Diarrhoea—Capecitabine—stomach cancer	4.14e-05	0.000174	CcSEcCtD
Tacrolimus—Nervous system disorder—Epirubicin—stomach cancer	4.14e-05	0.000174	CcSEcCtD
Tacrolimus—Dizziness—Docetaxel—stomach cancer	4.14e-05	0.000174	CcSEcCtD
Tacrolimus—Thrombocytopenia—Epirubicin—stomach cancer	4.13e-05	0.000173	CcSEcCtD
Tacrolimus—Hypertension—Doxorubicin—stomach cancer	4.13e-05	0.000173	CcSEcCtD
Tacrolimus—Tachycardia—Epirubicin—stomach cancer	4.12e-05	0.000173	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.11e-05	0.000172	CcSEcCtD
Tacrolimus—Skin disorder—Epirubicin—stomach cancer	4.1e-05	0.000172	CcSEcCtD
Tacrolimus—Hyperhidrosis—Epirubicin—stomach cancer	4.08e-05	0.000171	CcSEcCtD
Tacrolimus—Insomnia—Methotrexate—stomach cancer	4.08e-05	0.000171	CcSEcCtD
Tacrolimus—Myalgia—Doxorubicin—stomach cancer	4.07e-05	0.000171	CcSEcCtD
Tacrolimus—Chest pain—Doxorubicin—stomach cancer	4.07e-05	0.000171	CcSEcCtD
Tacrolimus—Arthralgia—Doxorubicin—stomach cancer	4.07e-05	0.000171	CcSEcCtD
Tacrolimus—Anxiety—Doxorubicin—stomach cancer	4.06e-05	0.00017	CcSEcCtD
Tacrolimus—Paraesthesia—Methotrexate—stomach cancer	4.05e-05	0.00017	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.04e-05	0.00017	CcSEcCtD
Tacrolimus—Discomfort—Doxorubicin—stomach cancer	4.02e-05	0.000169	CcSEcCtD
Tacrolimus—Anorexia—Epirubicin—stomach cancer	4.02e-05	0.000169	CcSEcCtD
Tacrolimus—Dyspnoea—Methotrexate—stomach cancer	4.02e-05	0.000169	CcSEcCtD
Tacrolimus—Somnolence—Methotrexate—stomach cancer	4.01e-05	0.000168	CcSEcCtD
Tacrolimus—Dizziness—Capecitabine—stomach cancer	4e-05	0.000168	CcSEcCtD
Tacrolimus—Dry mouth—Doxorubicin—stomach cancer	3.98e-05	0.000167	CcSEcCtD
Tacrolimus—Vomiting—Docetaxel—stomach cancer	3.98e-05	0.000167	CcSEcCtD
Tacrolimus—Dyspepsia—Methotrexate—stomach cancer	3.97e-05	0.000167	CcSEcCtD
Tacrolimus—Rash—Docetaxel—stomach cancer	3.94e-05	0.000165	CcSEcCtD
Tacrolimus—Hypotension—Epirubicin—stomach cancer	3.94e-05	0.000165	CcSEcCtD
Tacrolimus—Dermatitis—Docetaxel—stomach cancer	3.94e-05	0.000165	CcSEcCtD
Tacrolimus—Confusional state—Doxorubicin—stomach cancer	3.94e-05	0.000165	CcSEcCtD
Tacrolimus—Decreased appetite—Methotrexate—stomach cancer	3.92e-05	0.000164	CcSEcCtD
Tacrolimus—Headache—Docetaxel—stomach cancer	3.92e-05	0.000164	CcSEcCtD
Tacrolimus—Anaphylactic shock—Doxorubicin—stomach cancer	3.9e-05	0.000164	CcSEcCtD
Tacrolimus—Oedema—Doxorubicin—stomach cancer	3.9e-05	0.000164	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Methotrexate—stomach cancer	3.89e-05	0.000163	CcSEcCtD
Tacrolimus—Fatigue—Methotrexate—stomach cancer	3.89e-05	0.000163	CcSEcCtD
Tacrolimus—Infection—Doxorubicin—stomach cancer	3.88e-05	0.000163	CcSEcCtD
Tacrolimus—Pain—Methotrexate—stomach cancer	3.85e-05	0.000162	CcSEcCtD
Tacrolimus—Vomiting—Capecitabine—stomach cancer	3.85e-05	0.000162	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.84e-05	0.000161	CcSEcCtD
Tacrolimus—Shock—Doxorubicin—stomach cancer	3.84e-05	0.000161	CcSEcCtD
Tacrolimus—Nervous system disorder—Doxorubicin—stomach cancer	3.83e-05	0.000161	CcSEcCtD
Tacrolimus—Thrombocytopenia—Doxorubicin—stomach cancer	3.82e-05	0.00016	CcSEcCtD
Tacrolimus—Rash—Capecitabine—stomach cancer	3.82e-05	0.00016	CcSEcCtD
Tacrolimus—Insomnia—Epirubicin—stomach cancer	3.82e-05	0.00016	CcSEcCtD
Tacrolimus—Dermatitis—Capecitabine—stomach cancer	3.81e-05	0.00016	CcSEcCtD
Tacrolimus—Tachycardia—Doxorubicin—stomach cancer	3.81e-05	0.00016	CcSEcCtD
Tacrolimus—Headache—Capecitabine—stomach cancer	3.79e-05	0.000159	CcSEcCtD
Tacrolimus—Skin disorder—Doxorubicin—stomach cancer	3.79e-05	0.000159	CcSEcCtD
Tacrolimus—Paraesthesia—Epirubicin—stomach cancer	3.79e-05	0.000159	CcSEcCtD
Tacrolimus—Hyperhidrosis—Doxorubicin—stomach cancer	3.77e-05	0.000158	CcSEcCtD
Tacrolimus—Dyspnoea—Epirubicin—stomach cancer	3.76e-05	0.000158	CcSEcCtD
Tacrolimus—Somnolence—Epirubicin—stomach cancer	3.75e-05	0.000157	CcSEcCtD
Tacrolimus—Anorexia—Doxorubicin—stomach cancer	3.72e-05	0.000156	CcSEcCtD
Tacrolimus—Nausea—Docetaxel—stomach cancer	3.71e-05	0.000156	CcSEcCtD
Tacrolimus—Feeling abnormal—Methotrexate—stomach cancer	3.71e-05	0.000156	CcSEcCtD
Tacrolimus—Dyspepsia—Epirubicin—stomach cancer	3.71e-05	0.000156	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methotrexate—stomach cancer	3.69e-05	0.000155	CcSEcCtD
Tacrolimus—Decreased appetite—Epirubicin—stomach cancer	3.67e-05	0.000154	CcSEcCtD
Tacrolimus—Hypotension—Doxorubicin—stomach cancer	3.65e-05	0.000153	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Epirubicin—stomach cancer	3.64e-05	0.000153	CcSEcCtD
Tacrolimus—Fatigue—Epirubicin—stomach cancer	3.64e-05	0.000153	CcSEcCtD
Tacrolimus—Pain—Epirubicin—stomach cancer	3.61e-05	0.000151	CcSEcCtD
Tacrolimus—Constipation—Epirubicin—stomach cancer	3.61e-05	0.000151	CcSEcCtD
Tacrolimus—Nausea—Capecitabine—stomach cancer	3.6e-05	0.000151	CcSEcCtD
Tacrolimus—Urticaria—Methotrexate—stomach cancer	3.58e-05	0.00015	CcSEcCtD
Tacrolimus—Abdominal pain—Methotrexate—stomach cancer	3.56e-05	0.00015	CcSEcCtD
Tacrolimus—Body temperature increased—Methotrexate—stomach cancer	3.56e-05	0.00015	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.56e-05	0.000149	CcSEcCtD
Tacrolimus—Insomnia—Doxorubicin—stomach cancer	3.53e-05	0.000148	CcSEcCtD
Tacrolimus—Paraesthesia—Doxorubicin—stomach cancer	3.5e-05	0.000147	CcSEcCtD
Tacrolimus—Dyspnoea—Doxorubicin—stomach cancer	3.48e-05	0.000146	CcSEcCtD
Tacrolimus—Feeling abnormal—Epirubicin—stomach cancer	3.48e-05	0.000146	CcSEcCtD
Tacrolimus—Somnolence—Doxorubicin—stomach cancer	3.47e-05	0.000146	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Epirubicin—stomach cancer	3.45e-05	0.000145	CcSEcCtD
Tacrolimus—Dyspepsia—Doxorubicin—stomach cancer	3.44e-05	0.000144	CcSEcCtD
Tacrolimus—Decreased appetite—Doxorubicin—stomach cancer	3.39e-05	0.000142	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.37e-05	0.000141	CcSEcCtD
Tacrolimus—Fatigue—Doxorubicin—stomach cancer	3.36e-05	0.000141	CcSEcCtD
Tacrolimus—Urticaria—Epirubicin—stomach cancer	3.35e-05	0.000141	CcSEcCtD
Tacrolimus—Pain—Doxorubicin—stomach cancer	3.34e-05	0.00014	CcSEcCtD
Tacrolimus—Constipation—Doxorubicin—stomach cancer	3.34e-05	0.00014	CcSEcCtD
Tacrolimus—Abdominal pain—Epirubicin—stomach cancer	3.33e-05	0.00014	CcSEcCtD
Tacrolimus—Body temperature increased—Epirubicin—stomach cancer	3.33e-05	0.00014	CcSEcCtD
Tacrolimus—Hypersensitivity—Methotrexate—stomach cancer	3.32e-05	0.000139	CcSEcCtD
Tacrolimus—Asthenia—Methotrexate—stomach cancer	3.23e-05	0.000136	CcSEcCtD
Tacrolimus—Feeling abnormal—Doxorubicin—stomach cancer	3.22e-05	0.000135	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Doxorubicin—stomach cancer	3.19e-05	0.000134	CcSEcCtD
Tacrolimus—Pruritus—Methotrexate—stomach cancer	3.19e-05	0.000134	CcSEcCtD
Tacrolimus—Hypersensitivity—Epirubicin—stomach cancer	3.11e-05	0.00013	CcSEcCtD
Tacrolimus—Urticaria—Doxorubicin—stomach cancer	3.1e-05	0.00013	CcSEcCtD
Tacrolimus—Body temperature increased—Doxorubicin—stomach cancer	3.09e-05	0.000129	CcSEcCtD
Tacrolimus—Abdominal pain—Doxorubicin—stomach cancer	3.09e-05	0.000129	CcSEcCtD
Tacrolimus—Diarrhoea—Methotrexate—stomach cancer	3.08e-05	0.000129	CcSEcCtD
Tacrolimus—Asthenia—Epirubicin—stomach cancer	3.03e-05	0.000127	CcSEcCtD
Tacrolimus—Pruritus—Epirubicin—stomach cancer	2.98e-05	0.000125	CcSEcCtD
Tacrolimus—Dizziness—Methotrexate—stomach cancer	2.98e-05	0.000125	CcSEcCtD
Tacrolimus—Diarrhoea—Epirubicin—stomach cancer	2.89e-05	0.000121	CcSEcCtD
Tacrolimus—Hypersensitivity—Doxorubicin—stomach cancer	2.88e-05	0.000121	CcSEcCtD
Tacrolimus—Vomiting—Methotrexate—stomach cancer	2.87e-05	0.00012	CcSEcCtD
Tacrolimus—Rash—Methotrexate—stomach cancer	2.84e-05	0.000119	CcSEcCtD
Tacrolimus—Dermatitis—Methotrexate—stomach cancer	2.84e-05	0.000119	CcSEcCtD
Tacrolimus—Headache—Methotrexate—stomach cancer	2.82e-05	0.000119	CcSEcCtD
Tacrolimus—Asthenia—Doxorubicin—stomach cancer	2.8e-05	0.000118	CcSEcCtD
Tacrolimus—Dizziness—Epirubicin—stomach cancer	2.79e-05	0.000117	CcSEcCtD
Tacrolimus—Pruritus—Doxorubicin—stomach cancer	2.76e-05	0.000116	CcSEcCtD
Tacrolimus—Vomiting—Epirubicin—stomach cancer	2.68e-05	0.000113	CcSEcCtD
Tacrolimus—Nausea—Methotrexate—stomach cancer	2.68e-05	0.000112	CcSEcCtD
Tacrolimus—Diarrhoea—Doxorubicin—stomach cancer	2.67e-05	0.000112	CcSEcCtD
Tacrolimus—Rash—Epirubicin—stomach cancer	2.66e-05	0.000112	CcSEcCtD
Tacrolimus—Dermatitis—Epirubicin—stomach cancer	2.66e-05	0.000112	CcSEcCtD
Tacrolimus—Headache—Epirubicin—stomach cancer	2.64e-05	0.000111	CcSEcCtD
Tacrolimus—Dizziness—Doxorubicin—stomach cancer	2.58e-05	0.000108	CcSEcCtD
Tacrolimus—Nausea—Epirubicin—stomach cancer	2.51e-05	0.000105	CcSEcCtD
Tacrolimus—Vomiting—Doxorubicin—stomach cancer	2.48e-05	0.000104	CcSEcCtD
Tacrolimus—Rash—Doxorubicin—stomach cancer	2.46e-05	0.000103	CcSEcCtD
Tacrolimus—Dermatitis—Doxorubicin—stomach cancer	2.46e-05	0.000103	CcSEcCtD
Tacrolimus—Headache—Doxorubicin—stomach cancer	2.45e-05	0.000103	CcSEcCtD
Tacrolimus—Nausea—Doxorubicin—stomach cancer	2.32e-05	9.73e-05	CcSEcCtD
Tacrolimus—ABCB1—Metabolism—RORA—stomach cancer	9.75e-06	6.84e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6R—stomach cancer	9.75e-06	6.84e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MAPK1—stomach cancer	9.7e-06	6.81e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EGFR—stomach cancer	9.7e-06	6.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ALOX5—stomach cancer	9.69e-06	6.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APC—stomach cancer	9.69e-06	6.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2A6—stomach cancer	9.68e-06	6.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDH1—stomach cancer	9.66e-06	6.78e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	9.63e-06	6.76e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HRAS—stomach cancer	9.6e-06	6.74e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPP2R1A—stomach cancer	9.57e-06	6.72e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	9.55e-06	6.71e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DPYD—stomach cancer	9.53e-06	6.69e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MYC—stomach cancer	9.48e-06	6.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SMAD4—stomach cancer	9.41e-06	6.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKR1C3—stomach cancer	9.41e-06	6.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTP1—stomach cancer	9.39e-06	6.59e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB2—stomach cancer	9.37e-06	6.58e-05	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	9.33e-06	6.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—EGFR—stomach cancer	9.31e-06	6.54e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—stomach cancer	9.31e-06	6.53e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MAPK1—stomach cancer	9.28e-06	6.51e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EGFR—stomach cancer	9.27e-06	6.51e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HMOX1—stomach cancer	9.26e-06	6.5e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—STAT3—stomach cancer	9.21e-06	6.47e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—stomach cancer	9.19e-06	6.45e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ENO1—stomach cancer	9.17e-06	6.44e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—KRAS—stomach cancer	9.16e-06	6.43e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALDOB—stomach cancer	9.13e-06	6.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA1—stomach cancer	9.11e-06	6.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NDUFA2—stomach cancer	9.11e-06	6.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FBP1—stomach cancer	9.11e-06	6.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CKB—stomach cancer	9.11e-06	6.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6R—stomach cancer	9e-06	6.32e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FYN—stomach cancer	8.94e-06	6.27e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	8.91e-06	6.26e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—stomach cancer	8.88e-06	6.24e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAPK3—stomach cancer	8.8e-06	6.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—KRAS—stomach cancer	8.8e-06	6.18e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	8.78e-06	6.16e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—KRAS—stomach cancer	8.76e-06	6.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TYMS—stomach cancer	8.73e-06	6.13e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN1B—stomach cancer	8.68e-06	6.09e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.64e-06	6.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTM1—stomach cancer	8.63e-06	6.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLIN2—stomach cancer	8.56e-06	6.01e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MYC—stomach cancer	8.56e-06	6.01e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPINE1—stomach cancer	8.55e-06	6e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALOX5—stomach cancer	8.49e-06	5.96e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.49e-06	5.96e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTT1—stomach cancer	8.43e-06	5.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SERPINE1—stomach cancer	8.43e-06	5.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PIK3CA—stomach cancer	8.42e-06	5.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGFR2—stomach cancer	8.39e-06	5.89e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAPK1—stomach cancer	8.38e-06	5.88e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EGFR—stomach cancer	8.38e-06	5.88e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DPYD—stomach cancer	8.35e-06	5.86e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2A6—stomach cancer	8.33e-06	5.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA2—stomach cancer	8.33e-06	5.85e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCND1—stomach cancer	8.28e-06	5.81e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—JUN—stomach cancer	8.26e-06	5.8e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—RHOA—stomach cancer	8.25e-06	5.79e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	8.17e-06	5.74e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS3—stomach cancer	8.16e-06	5.73e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB2—stomach cancer	8.15e-06	5.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CD44—stomach cancer	8.14e-06	5.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RHOA—stomach cancer	8.13e-06	5.71e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PGAM1—stomach cancer	8.12e-06	5.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NT5E—stomach cancer	8.12e-06	5.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ERCC2—stomach cancer	8.11e-06	5.69e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKR1C3—stomach cancer	8.11e-06	5.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PIK3CA—stomach cancer	8.08e-06	5.67e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PIK3CA—stomach cancer	8.05e-06	5.65e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS3—stomach cancer	8.04e-06	5.65e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—stomach cancer	8.04e-06	5.64e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN1A—stomach cancer	8.01e-06	5.62e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KRAS—stomach cancer	7.91e-06	5.55e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ENO1—stomach cancer	7.9e-06	5.55e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK8—stomach cancer	7.82e-06	5.49e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—HRAS—stomach cancer	7.79e-06	5.47e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.74e-06	5.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLCE1—stomach cancer	7.74e-06	5.44e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS2—stomach cancer	7.68e-06	5.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—stomach cancer	7.62e-06	5.35e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDKN1B—stomach cancer	7.55e-06	5.3e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB2—stomach cancer	7.52e-06	5.28e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HRAS—stomach cancer	7.48e-06	5.25e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—stomach cancer	7.45e-06	5.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CAV1—stomach cancer	7.45e-06	5.23e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HRAS—stomach cancer	7.45e-06	5.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOA1—stomach cancer	7.43e-06	5.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—UMPS—stomach cancer	7.43e-06	5.21e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—stomach cancer	7.41e-06	5.2e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTT1—stomach cancer	7.39e-06	5.19e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—stomach cancer	7.36e-06	5.17e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2A6—stomach cancer	7.3e-06	5.13e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PIK3CA—stomach cancer	7.27e-06	5.1e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—stomach cancer	7.22e-06	5.07e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—JUN—stomach cancer	7.18e-06	5.04e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—STAT3—stomach cancer	7.15e-06	5.02e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—stomach cancer	7.13e-06	5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKR1C3—stomach cancer	7.1e-06	4.99e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRKCB—stomach cancer	7.09e-06	4.98e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6ST—stomach cancer	7.06e-06	4.96e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAV1—stomach cancer	7.03e-06	4.94e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—stomach cancer	7.03e-06	4.94e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOA1—stomach cancer	7.02e-06	4.93e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CD44—stomach cancer	7.01e-06	4.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN1B—stomach cancer	6.97e-06	4.89e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDKN1A—stomach cancer	6.97e-06	4.89e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ENO1—stomach cancer	6.92e-06	4.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPP2R1A—stomach cancer	6.92e-06	4.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PDHA1—stomach cancer	6.9e-06	4.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ECHS1—stomach cancer	6.9e-06	4.85e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK3—stomach cancer	6.83e-06	4.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK8—stomach cancer	6.8e-06	4.77e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.8e-06	4.77e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APC—stomach cancer	6.79e-06	4.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTP1—stomach cancer	6.79e-06	4.76e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HRAS—stomach cancer	6.73e-06	4.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMOX1—stomach cancer	6.69e-06	4.7e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MYC—stomach cancer	6.64e-06	4.66e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK1—stomach cancer	6.5e-06	4.56e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EGFR—stomach cancer	6.49e-06	4.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TYMP—stomach cancer	6.49e-06	4.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FADS1—stomach cancer	6.49e-06	4.56e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	6.47e-06	4.54e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—stomach cancer	6.44e-06	4.52e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN1A—stomach cancer	6.43e-06	4.51e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TYMS—stomach cancer	6.31e-06	4.43e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6R—stomach cancer	6.3e-06	4.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—stomach cancer	6.24e-06	4.38e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—STAT3—stomach cancer	6.22e-06	4.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—stomach cancer	6.18e-06	4.34e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CD44—stomach cancer	6.14e-06	4.31e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KRAS—stomach cancer	6.13e-06	4.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SREBF2—stomach cancer	6.08e-06	4.27e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—RORA—stomach cancer	6.01e-06	4.22e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPP2R1A—stomach cancer	5.96e-06	4.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK3—stomach cancer	5.94e-06	4.17e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—stomach cancer	5.9e-06	4.14e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—stomach cancer	5.88e-06	4.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ERCC2—stomach cancer	5.86e-06	4.12e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTP1—stomach cancer	5.84e-06	4.1e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMOX1—stomach cancer	5.76e-06	4.05e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—STAT3—stomach cancer	5.74e-06	4.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RHOA—stomach cancer	5.69e-06	4e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK1—stomach cancer	5.65e-06	3.97e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EGFR—stomach cancer	5.65e-06	3.97e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PIK3CA—stomach cancer	5.64e-06	3.96e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—stomach cancer	5.63e-06	3.95e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALDOB—stomach cancer	5.63e-06	3.95e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MAPK3—stomach cancer	5.56e-06	3.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—stomach cancer	5.56e-06	3.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—stomach cancer	5.51e-06	3.87e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MAPK3—stomach cancer	5.48e-06	3.85e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—stomach cancer	5.45e-06	3.83e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TYMS—stomach cancer	5.43e-06	3.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—stomach cancer	5.37e-06	3.77e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KRAS—stomach cancer	5.34e-06	3.75e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MYC—stomach cancer	5.33e-06	3.74e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—stomach cancer	5.32e-06	3.73e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MAPK1—stomach cancer	5.29e-06	3.72e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB2—stomach cancer	5.27e-06	3.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALOX5—stomach cancer	5.23e-06	3.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPP2R1A—stomach cancer	5.22e-06	3.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MAPK1—stomach cancer	5.22e-06	3.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EGFR—stomach cancer	5.22e-06	3.66e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HRAS—stomach cancer	5.21e-06	3.66e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DPYD—stomach cancer	5.15e-06	3.61e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTP1—stomach cancer	5.12e-06	3.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAV1—stomach cancer	5.08e-06	3.57e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOA1—stomach cancer	5.07e-06	3.56e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMOX1—stomach cancer	5.05e-06	3.54e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ERCC2—stomach cancer	5.05e-06	3.54e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—KRAS—stomach cancer	5e-06	3.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—stomach cancer	5e-06	3.51e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—stomach cancer	4.99e-06	3.5e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—KRAS—stomach cancer	4.93e-06	3.46e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PIK3CA—stomach cancer	4.9e-06	3.44e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN1B—stomach cancer	4.88e-06	3.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—stomach cancer	4.86e-06	3.41e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TYMS—stomach cancer	4.76e-06	3.34e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—stomach cancer	4.75e-06	3.33e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—stomach cancer	4.71e-06	3.3e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCND1—stomach cancer	4.66e-06	3.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—JUN—stomach cancer	4.65e-06	3.26e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PIK3CA—stomach cancer	4.59e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTT1—stomach cancer	4.55e-06	3.2e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HRAS—stomach cancer	4.54e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PIK3CA—stomach cancer	4.53e-06	3.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—stomach cancer	4.52e-06	3.17e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN1A—stomach cancer	4.5e-06	3.16e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.5e-06	3.16e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—stomach cancer	4.47e-06	3.14e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—stomach cancer	4.44e-06	3.12e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ERCC2—stomach cancer	4.42e-06	3.11e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK8—stomach cancer	4.4e-06	3.09e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAV1—stomach cancer	4.38e-06	3.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.38e-06	3.07e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOA1—stomach cancer	4.37e-06	3.07e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—stomach cancer	4.34e-06	3.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ENO1—stomach cancer	4.26e-06	2.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HRAS—stomach cancer	4.25e-06	2.98e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HRAS—stomach cancer	4.19e-06	2.94e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.18e-06	2.94e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—stomach cancer	4.16e-06	2.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—stomach cancer	4.06e-06	2.85e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STAT3—stomach cancer	4.02e-06	2.82e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—stomach cancer	4.02e-06	2.82e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—stomach cancer	4.01e-06	2.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—stomach cancer	3.85e-06	2.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—stomach cancer	3.84e-06	2.7e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK3—stomach cancer	3.84e-06	2.7e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAV1—stomach cancer	3.84e-06	2.69e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOA1—stomach cancer	3.83e-06	2.69e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CD44—stomach cancer	3.78e-06	2.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MYC—stomach cancer	3.73e-06	2.62e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK1—stomach cancer	3.65e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EGFR—stomach cancer	3.65e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—stomach cancer	3.52e-06	2.47e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KRAS—stomach cancer	3.45e-06	2.42e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—stomach cancer	3.37e-06	2.37e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—stomach cancer	3.31e-06	2.32e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.22e-06	2.26e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PIK3CA—stomach cancer	3.17e-06	2.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTP1—stomach cancer	3.15e-06	2.21e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMOX1—stomach cancer	3.11e-06	2.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—stomach cancer	3.07e-06	2.15e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—stomach cancer	3.03e-06	2.13e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—stomach cancer	3.03e-06	2.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.99e-06	2.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TYMS—stomach cancer	2.93e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HRAS—stomach cancer	2.93e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—stomach cancer	2.9e-06	2.04e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—stomach cancer	2.9e-06	2.04e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—stomach cancer	2.81e-06	1.97e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ERCC2—stomach cancer	2.73e-06	1.91e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—stomach cancer	2.65e-06	1.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—stomach cancer	2.56e-06	1.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAV1—stomach cancer	2.36e-06	1.66e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOA1—stomach cancer	2.36e-06	1.66e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.16e-06	1.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—stomach cancer	2.08e-06	1.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—stomach cancer	1.87e-06	1.31e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3CA—stomach cancer	1.86e-06	1.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—stomach cancer	1.79e-06	1.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—stomach cancer	1.63e-06	1.15e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3CA—stomach cancer	1.63e-06	1.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.01e-06	7.06e-06	CbGpPWpGaD
